SG11201600497VA - Novel triazine derivative - Google Patents

Novel triazine derivative

Info

Publication number
SG11201600497VA
SG11201600497VA SG11201600497VA SG11201600497VA SG11201600497VA SG 11201600497V A SG11201600497V A SG 11201600497VA SG 11201600497V A SG11201600497V A SG 11201600497VA SG 11201600497V A SG11201600497V A SG 11201600497VA SG 11201600497V A SG11201600497V A SG 11201600497VA
Authority
SG
Singapore
Prior art keywords
triazine derivative
novel triazine
novel
derivative
triazine
Prior art date
Application number
SG11201600497VA
Other languages
English (en)
Inventor
Wataru Kawahata
Tokiko ASAMI
Masaaki Sawa
Yuko ASAMITSU
Takayuki Irie
Takahiro Miyake
Takao Kiyoi
Original Assignee
Carna Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carna Biosciences Inc filed Critical Carna Biosciences Inc
Publication of SG11201600497VA publication Critical patent/SG11201600497VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG11201600497VA 2013-07-26 2014-07-15 Novel triazine derivative SG11201600497VA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2013155331 2013-07-26
JP2013187987 2013-09-11
JP2014073227 2014-03-31
PCT/JP2014/068752 WO2015012149A1 (ja) 2013-07-26 2014-07-15 新規トリアジン誘導体

Publications (1)

Publication Number Publication Date
SG11201600497VA true SG11201600497VA (en) 2016-02-26

Family

ID=52393193

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201600497VA SG11201600497VA (en) 2013-07-26 2014-07-15 Novel triazine derivative

Country Status (15)

Country Link
US (1) US9656995B2 (zh)
EP (1) EP3026050B1 (zh)
JP (1) JP6156953B2 (zh)
KR (1) KR101742550B1 (zh)
CN (1) CN105683178B (zh)
AU (1) AU2014294225B2 (zh)
CA (1) CA2919068C (zh)
CR (1) CR20160082A (zh)
DK (1) DK3026050T3 (zh)
ES (1) ES2699452T3 (zh)
IL (1) IL243737B (zh)
NO (1) NO20160292A1 (zh)
PH (1) PH12016500152A1 (zh)
SG (1) SG11201600497VA (zh)
WO (1) WO2015012149A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160221991A1 (en) * 2013-09-20 2016-08-04 Carna Biosciences, Inc. Novel triazine derivative
AU2017364720B2 (en) * 2016-11-25 2021-09-23 Carna Biosciences, Inc. Novel oxoisoquinoline derivative
WO2021157650A1 (ja) 2020-02-05 2021-08-12 カルナバイオサイエンス株式会社 抗がん剤組成物
WO2022034914A1 (ja) * 2020-08-13 2022-02-17 カルナバイオサイエンス株式会社 易溶性固形製剤およびその製法
WO2022102715A1 (ja) * 2020-11-13 2022-05-19 カルナバイオサイエンス株式会社 組み合わせ医薬組成物および治療方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009265813B2 (en) 2008-07-02 2014-04-10 F. Hoffmann-La Roche Ag Novel phenylpyrazinones as kinase inhibitors
US8299077B2 (en) 2009-03-02 2012-10-30 Roche Palo Alto Llc Inhibitors of Bruton's tyrosine kinase
KR20140052032A (ko) 2011-08-17 2014-05-02 에프. 호프만-라 로슈 아게 브루톤 티로신 키나아제의 억제제
KR101673728B1 (ko) * 2011-12-09 2016-11-07 에프. 호프만-라 로슈 아게 브루톤 티로신 키나아제의 억제제
US20150011751A1 (en) * 2012-03-09 2015-01-08 Carna Biosciences, Inc. Novel triazine derivative
WO2013161848A1 (ja) 2012-04-27 2013-10-31 カルナバイオサイエンス株式会社 新規1,2,4-トリアジン誘導体

Also Published As

Publication number Publication date
CN105683178A (zh) 2016-06-15
EP3026050A4 (en) 2016-12-14
IL243737B (en) 2019-09-26
IL243737A0 (en) 2016-04-21
JPWO2015012149A1 (ja) 2017-03-02
US20160168122A1 (en) 2016-06-16
EP3026050A1 (en) 2016-06-01
CN105683178B (zh) 2019-04-12
CA2919068C (en) 2018-03-20
ES2699452T3 (es) 2019-02-11
US9656995B2 (en) 2017-05-23
CR20160082A (es) 2016-06-08
DK3026050T3 (en) 2019-02-18
CA2919068A1 (en) 2015-01-29
JP6156953B2 (ja) 2017-07-05
AU2014294225B2 (en) 2017-02-23
PH12016500152A1 (en) 2016-04-25
EP3026050B1 (en) 2018-11-07
KR20160041946A (ko) 2016-04-18
NO20160292A1 (en) 2016-02-19
AU2014294225A1 (en) 2016-03-03
KR101742550B1 (ko) 2017-06-01
WO2015012149A1 (ja) 2015-01-29

Similar Documents

Publication Publication Date Title
HK1222846A1 (zh) 取代的苄基吡唑
HK1221717A1 (zh) 取代的苄基吡唑
HK1215795A1 (zh) 鵝膏毒素衍生物
EP2824099A4 (en) NOVEL TRIAZINE DERIVATIVE
SG11201506100XA (en) Pyridazinone-amides derivatives
HRP20171890T1 (hr) Supstituirani imidazopiridazini
ZA201601333B (en) Oxoquinazolinyl-butanamide derivatives
HK1223362A1 (zh) 取代的吡唑並吡啶胺
HK1220972A1 (zh) 取代的噻唑並嘧啶
SG11201605189YA (en) Imidazopyrazinone derivatives
IL246271A0 (en) Converted piperidinyl-tetrahydroquinolines
IL241293B (en) New triazole derivatives
IL243737A0 (en) A new derivative of triazine
IL241859B (en) Novel triazole derivatives
HK1213566A1 (zh) 新的四唑酮衍生物
IL244664A0 (en) A new derivative of triazine
EP3009444A4 (en) ALPHA-oxoacyl-Amino-caprolactam derivative